Ketamine Does NOT Increase ICP in Traumatic Brain Injury Patients
Yes, the concern about ketamine raising intracranial pressure has been debunked—ketamine can be safely used for sedation in intubated patients with traumatic brain injury and may actually decrease ICP while maintaining cerebral perfusion pressure.
The Evidence Contradicts the FDA Label
The FDA label for ketamine still carries a precautionary statement about increased cerebrospinal fluid pressure 1, but this warning is based on outdated data from poorly controlled studies. This creates a disconnect between regulatory labeling and contemporary clinical evidence.
What the Current Research Shows
Multiple systematic reviews and meta-analyses from 2020-2026 consistently demonstrate:
No clinically significant ICP elevation: A 2020 systematic review found only 2 studies showing small ICP increases, while 2 studies actually found decreased ICP following ketamine administration 2. A 2026 meta-analysis showed no statistically significant difference in ICP elevation between ketamine and no-ketamine groups in patients with baseline ICP < 20 mmHg (RR = 0.67; 95% CI [0.45,1.01]) 3.
No mortality difference: Hospital mortality showed no statistically significant difference between ketamine and other sedatives (RR = 1.18; 95% CI [0.90,1.55]) 3.
Potential neuroprotective effects: Preclinical studies indicate ketamine exhibits neuroprotective and anti-neuroinflammatory properties 4.
Important Clinical Considerations
Hemodynamic effects to monitor: The most recent 2026 meta-analysis found a controversial association with hypotension episodes (RR = 1.47; 95% CI [1.22,1.78]) 3. This is clinically relevant because maintaining cerebral perfusion pressure is critical in TBI management.
When to use ketamine in TBI:
- For rapid sequence intubation in the prehospital or emergency setting
- As an adjunct sedative in mechanically ventilated patients with ICP monitoring
- When other sedatives (propofol, midazolam) cause hemodynamic instability or require escalating doses
Monitoring requirements: Patients with elevated ICP should be in a monitored setting with frequent neurologic assessments 1, which is standard practice for severe TBI regardless of sedative choice.
The Guideline Perspective
The 2018 severe TBI guideline 5 does not specifically address ketamine use, recommending continuous sedation and correction of hypotension but remaining agnostic about specific agents. The guideline notes that "no evidence was found that one sedative or opioid agent provided more efficacy than another in TBI patients" and warns that "arterial hypotension can be observed with barbiturates, bolus of midazolam, or bolus of opioids" 5.
Clinical Bottom Line
Use ketamine confidently in TBI patients requiring sedation and intubation, with standard ICP and hemodynamic monitoring. The historical contraindication is not supported by contemporary evidence 6, 7, 8. Ketamine offers advantages including preserved hemodynamic stability (compared to propofol/midazolam), maintained airway reflexes, and potential neuroprotection. The main caveat is monitoring for hypotension, which may paradoxically be more common than previously thought 3.